1 Ferlay J,Soerjomataram I,Dikshit R,et al.Cancer incidence and mortality worldwide:sources,methods and major patterns in GLOBOCAN 2012[J].Int J Cancer,2015,136(5):359-386. 2 Zheng R,Zeng H,Zhang S,et al.Estimates of cancer incidence and mortality in China,2013[J].Chin J Cancer,2017,36(1):66. 3 Allemani C,Weir HK,Carreira H,et al.Global surveillance of cancer survival 1995-2009:analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries(CONCORD-2)[J].Lancet,2015,385(9972):977-1010. 4 Blandin Knight S,Crosbie PA,Balata H,et al.Progress and prospects of early detection in lung cancer[J].Open Biol,2017,7(9):170070. 5 Ost DE,Gould MK.Decision making in patients with pulmonary nodules[J].Am J Respir Crit Care Med,2012,185(4):363-372. 6 Chen W,Zheng R,Zhang S,et al.Cancer incidence and mortality in China in 2013:an analysis based on urbanization level[J].Chin J Cancer Res,2017,29(1):1-10. 7 Chen W,Zheng R,Baade PD,et al.Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66(2):115-132. 8 Global Burden of Disease Cancer Collaboration,Fitzmaurice C,Dicker D,et al.The global burden of cancer 2013[J].JAMA Oncol,2015,1(4):505-527. 9 National Lung Screening Trial Research Team,Aberle DR,Adams AM,et al.Reduced lung-cancer mortality with low-dose computed tomographic screening[J].N Engl J Med,2011,365(5):395-409. 10 Sheehan DF,Criss SD,Gazelle GS,et al.Evaluating lung cancer screening in China:Implications for eligibility criteria design from a microsimulation modeling approach[J].PLoS One,2017,12(3):e0173119. 11 Hu J,Qian GS,Bai CX,et al.Chinese consensus on early diagnosis of primary lung cancer(2014 version)[J].Cancer,2015,121(17):3157-3164. 12 Gould MK,Donington J,Lynch WR,et al.Evaluation of individuals with pulmonary nodules:when is it lung cancer? Diagnosis and management of lung cancer,3rd ed:American College of Chest Physicians evidence-based clinical practice guidelines[J].Chest,2013,143(5):93-120. 13 Zhang Y,Hong QY,Shi WB,et al.Value of low-dose spiral computed tomography in lung cancer screening[J].Zhonghua Yi Xue Za Zhi,2013,93(38):3011-3014. 14 Chen NA,Ma J.A multivariate risk factors analysis study contributing to solitary pulmonary nodules[J].Chin J Clinicians,2014,8(14):2602-2607. 15 Cho J,Kim ES,Kim SJ,et al.Long-term follow-up of small pulmonary ground-glass nodules stable for 3 years:implications of the proper follow-up period and risk factors for subsequent growth[J].J Thorac Oncol,2016,11(9):1453-1459. 16 Wen CP,Zhang F,Liang D,et al.The ability of bilirubin in identifying smokers with higher risk of lung cancer:a large cohort study in conjunction with global metabolomic profiling[J].Clin Cancer Res,2015,21(1):193-200. 17 Swensen SJ,Jett JR,Sloan JA,et al.Screening for lung cancer with low-dose spiral computed tomography[J].Am J Respir Crit Care Med,2002,165:508-513. 18 Kwon M,Lee SH,Lee YS,et al.Clinical implications of nonspecific pulmonary nodules identified during the initial evaluation of patients with head and neck squamous cell carcinoma[J].Eur Radiol,2017,27(9):3725-3732. 19 Gould MK,Ananth L,Barnett PG,et al.A clinical model to estimate the pretest probability of lung cancer in patients with solitary pulmonary nodules[J].Chest,2007,131(2):383-388. 20 Ten Haaf K,de Koning HJ.Should never-smokers at increased risk for lung cancer be screened?[J].J Thorac Oncol,2015,10(9):1285-1291. 21 唐威,吴宁,黄遥,等.4690例无症状健康体检者低剂量CT早期肺癌筛查研究[J].中华肿瘤杂志,2014,36(7):549-554. 22 Shinohara S,Hanagiri T,Takenaka M,et al.Evaluation of undiagnosed solitary lung nodules according to the probability of malignancy in the American College of Chest Physicians(ACCP)evidence-based clinical practice guidelines[J].Radiol Oncol,2014,48(1):50-55. 23 Mehta HJ,Ravenel JG,Shaftman SR,et al.The utility of nodule volume in the context of malignancy prediction for small pulmonary nodules[J].Chest,2014,145(3):464-472. 24 Detterbeck FC,Lewis SZ,Diekemper R,et al.Executive Summary:Diagnosis and management of lung cancer,3rded:American College of Chest Physicians evidence-based clinical practice guidelines[J].Chest,2013,143(5):7-37. 25 MacMahon H,Naidich DP,Goo JM,et al.Guidelines for management of incidental pulmonary nodules detected on ct images:from the fleischner society 2017[J].Radiology,2017,284(1):228-243. 26 Naidich DP,Bankier AA,Macmabon H,et al.Recommendations for the management of subsolid pulmonary nodules detedted at CT:a statement from the Fleischner Society[J].Radiology,2013,266(1):304-317. 27 Boiselle PM,White CS,Ravenel JG.Computed tomographic screening for lung cancer:current practice patterns at leading academic medical centers[J].JAMA Intern Med,2014,174(2):286-287. 28 Kim SY,Lee KS,Han J,et al.Persistent pulmonary nodular ground-glass opacity at thin-section CT histopathologic comparisons[J].Radiology,2007,245(1):267-275. 29 Mets OM,de Jong PA,Scholten ET,et al.Subsolid pulmonary nodule morphology and associated patient characteristics in a routine clinical population[J].Eur Radiol,2017,27(2):689-696. 30 Silva M,Bankier AA,Centra F,et al.Longitudinal evolution of incidentally detected solitary pure ground-glass nodules on CT:relation to clinical metrics[J].Diagn Interv Radiol,2015,21(5):385-390. 31 Bellier J,Perentes JY,Abdelnour-Berchtold E,et al.A plea for thoracoscopic resection of solitary pulmonary nodulein cancer patients[J].Surg Endosc,2017,31(11):4705-4710. 32 Horeweg N,van der Aalst CM,Thunnissen E,et al.Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial[J].Am J Respir Crit Care Med,2013,187(8):848-854. 33 王欣悦,韩融诚,郭芳芳,等.不同类型肺结节的生长曲线分析[J].中国肺癌杂志,2017,20(5):334-340. 34 Winer-Muram HT.The solitary pulmonary nodule[J].Radiology,2006,239(1):34-49. 35 Yang W,Sun Y,Fang W,et al.High-resolution computed tomography features distinguishing benign and malignant lesions manifesting as persistent solitary subsolid nodules[J].Clin Lung Cancer,2017,7304(17)30172-30179. 36 喻微,叶波,续力云,等.实性孤立性肺结节诊断模型的建立[J].中国肺癌杂志,2016,10(19):705-710. |